| A primer to frequent itemset mining for bioinformatics S Naulaerts, P Meysman, W Bittremieux, TN Vu, W Vanden Berghe, ... Briefings in bioinformatics 16 (2), 216-231, 2015 | 170 | 2015 |
| Predicting synergism of cancer drug combinations using NCI-ALMANAC data P Sidorov, S Naulaerts, J Ariey-Bonnet, E Pasquier, PJ Ballester Frontiers in chemistry 7, 509, 2019 | 126 | 2019 |
| Predicting the Reliability of Drug-target Interaction Predictions with Maximum Coverage of Target Space A Peón, S Naulaerts, PJ Ballester Scientific Reports 7, 3820, 2017 | 66 | 2017 |
| Withaferin A induces heme oxygenase (HO-1) expression in endothelial cells via activation of the Keap1/Nrf2 pathway K Heyninck, L Sabbe, CS Chirumamilla, KS vel Szic, P Vander Veken, ... Biochemical pharmacology 109, 48-61, 2016 | 65 | 2016 |
| Trial watch: Dendritic cell (DC)-based immunotherapy for cancer RS Laureano, J Sprooten, I Vanmeerbeerk, DM Borras, J Govaerts, ... Oncoimmunology 11 (1), 2096363, 2022 | 64 | 2022 |
| Bioinformatics approaches for the functional interpretation of protein lists: from ontology term enrichment to network analysis K Laukens, S Naulaerts, WV Berghe Proteomics 15 (5-6), 981-996, 2015 | 50 | 2015 |
| Mining association rules in graphs based on frequent cohesive itemsets T Hendrickx, B Cule, P Meysman, S Naulaerts, K Laukens, B Goethals Advances in Knowledge Discovery and Data Mining: 19th Pacific-Asia …, 2015 | 45 | 2015 |
| Ectopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cells A Palagani, K Op de Beeck, S Naulaerts, J Diddens, ... PLoS One 9 (12), e113842, 2014 | 43 | 2014 |
| Osmotic stress inhibits leaf growth of Arabidopsis thaliana by enhancing ARF‐mediated auxin responses S Kalve, BL Sizani, MN Markakis, C Helsmoortel, G Vandeweyer, ... new phytologist 226 (6), 1766-1780, 2020 | 37 | 2020 |
| Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumours S Naulaerts, CC Dang, PJ Ballester Oncotarget 8 (57), 97025, 2017 | 31 | 2017 |
| Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of … P Meysman, B Ogunjimi, S Naulaerts, P Beutels, V Van Tendeloo, ... Journal of virology 89 (2), 962-969, 2015 | 26 | 2015 |
| Trial watch: chemotherapy-induced immunogenic cell death in oncology J Sprooten, RS Laureano, I Vanmeerbeek, J Govaerts, S Naulaerts, ... Oncoimmunology 12 (1), 2219591, 2023 | 17 | 2023 |
| Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer S Naulaerts, A Datsi, DM Borras, A Antoranz Martinez, J Messiaen, ... Science Translational Medicine 15 (691), eadd1016, 2023 | 17 | 2023 |
| Tumour immune rejection triggered by activation of α2-adrenergic receptors J Zhu, S Naulaerts, L Boudhan, M Martin, L Gatto, BJ Van den Eynde Nature 618 (7965), 607-615, 2023 | 14 | 2023 |
| Predicting cancer drug response in vivo by learning an optimal feature selection of tumour molecular profiles LC Nguyen, S Naulaerts, A Bruna, G Ghislat, PJ Ballester Biomedicines 9 (10), 1319, 2021 | 13 | 2021 |
| Concise polygenic models for cancer-specific identification of drug-sensitive tumors from their multi-omics profiles S Naulaerts, MP Menden, PJ Ballester Biomolecules 10 (6), 963, 2020 | 13 | 2020 |
| Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes M Solvay, P Holfelder, S Klaessens, L Pilotte, V Stroobant, J Lamy, ... Journal for Immunotherapy of Cancer 11 (6), 2023 | 11 | 2023 |
| The interface of tumour-associated macrophages with dying cancer cells in immuno-oncology I Vanmeerbeek, J Govaerts, RS Laureano, J Sprooten, S Naulaerts, ... Cells 11 (23), 3890, 2022 | 11 | 2022 |
| Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer DM Borràs, S Verbandt, M Ausserhofer, G Sturm, J Lim, GA Verge, ... Cell Discovery 9 (1), 114, 2023 | 9 | 2023 |
| T cell–mediated targeted delivery of anti–PD-L1 nanobody overcomes poor antibody penetration and improves PD-L1 blocking at the tumor site PF Petit, R Bombart, PH Desimpel, S Naulaerts, L Thouvenel, JF Collet, ... Cancer Immunology Research 10 (6), 713-727, 2022 | 7 | 2022 |
Kris LaukensProfessor Biodata Mining & Bioinformatics, University of AntwerpVerified email at uantwerpen.be
